论文部分内容阅读
目的:研究分析西药联合加味参附汤治疗缓慢性心律失常的临床有效性。方法:选取本院于2014年10月至2015年10月收治的62例缓慢性心律失常患者作为主要的研究对象,将上述患者随机分成对照组以及观察组各31例,给予对照组阿托品治疗,给予观察组西药联合加味参附汤治疗,以1个月为1个治疗疗程,比较两组患者的心率变化情况。结果:在完成治疗之后,观察组患者的治疗总有效率为96.77%,对照组患者的治疗总有效率为83.87%,观察组患者的临床症状以及体征改善程度明显优于对照组(P<0.05)。结论:在缓慢性心律失常患者治疗过程中,西药联合加味参附汤有较好的临床治疗效果。
Objective: To study and analyze the clinical efficacy of western medicine combined with Modified Shenfu Decoction in the treatment of bradyarrhythmia. Methods: Sixty-two patients with bradyarrhythmia admitted from October 2014 to October 2015 in our hospital were selected as the main study subjects. The patients were randomly divided into control group and observation group of 31 cases each. Patients in control group received atropine treatment, The observation group was given western medicine combined with Shenfu decoction to treat one month as a course of treatment to compare the change of heart rate between the two groups. Results: After the completion of treatment, the total effective rate of the observation group was 96.77%, while that of the control group was 83.87%. The clinical symptoms and signs of the observation group were better than those of the control group (P <0.05) ). Conclusion: In the course of treatment of patients with chronic arrhythmia, western medicine combined with Modified Shenfu Decoction has a better clinical effect.